Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “de Novo Liver Transplantation”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Large-scale testing (Phase 3)Study completedNCT00622869
What this trial is testing

Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 719
Post-approval studies (Phase 4)Study completedNCT01551212
What this trial is testing

Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 339
Large-scale testing (Phase 3)Study completedNCT00604357
What this trial is testing

CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment

Who this might be right for
End Stage Liver DiseaseImpaired Renal Function
University of Regensburg 27
Post-approval studies (Phase 4)Study completedNCT03619837
What this trial is testing

Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant

Who this might be right for
Hepatitis CTransplantation Disease Transmission
University of California, San Francisco 122
Post-approval studies (Phase 4)Study completedNCT05152628
What this trial is testing

Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Who this might be right for
Liver TransplantationKidney Transplantation
Astellas Pharma China, Inc. 55
Not applicableEnded earlyNCT02056054
What this trial is testing

De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation

Who this might be right for
De Novo Autoimmune Hepatitis
Yale University 157
Post-approval studies (Phase 4)Study completedNCT01018914
What this trial is testing

Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patients

Who this might be right for
Liver Transplantation
Astellas Pharma Inc 44
Post-approval studies (Phase 4)Looking for participantsNCT05089604
What this trial is testing

Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations

Who this might be right for
Liver TransplantationImmunosuppressionNeurotoxicity+2 more
University of British Columbia 124
Large-scale testing (Phase 3)Study completedNCT00149890
What this trial is testing

Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids

Who this might be right for
Liver TransplantationInfection
Novartis 77
Testing effectiveness (Phase 2)UnknownNCT01423708
What this trial is testing

Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study

Who this might be right for
Liver FailureLiver DiseasesLiver Cirrhosis+1 more
Azienda Ospedaliera di Padova 117
Post-approval studies (Phase 4)Study completedNCT01882322
What this trial is testing

Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects

Who this might be right for
de Novo Liver Transplant Subjects
Astellas Pharma Korea, Inc. 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT06019507
What this trial is testing

TCD601 in the Induction of Tolerance in de Novo Liver Transplantation

Who this might be right for
Liver Transplantation
ITB-Med LLC 12
Not applicableStudy completedNCT00710801
What this trial is testing

Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation

Who this might be right for
Hepatitis C Virus
University of Alberta 40
Post-approval studies (Phase 4)Study completedNCT00343226
What this trial is testing

An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.

Who this might be right for
Liver Transplantation
Novartis 48
Not applicableStudy completedNCT06290726
What this trial is testing

Long-term Outcomes of Living Donor Liver Transplantations With Anti-HBc (+) Grafts in Pediatric Patients

Who this might be right for
Living Donor Liver Transplantations With Anti-HBc (+) Grafts
Chang Gung Memorial Hospital 204
Large-scale testing (Phase 3)WithdrawnNCT02909335
What this trial is testing

De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised Study

Who this might be right for
Liver Transplantation
Rennes University Hospital
Testing effectiveness (Phase 2)UnknownNCT00890253
What this trial is testing

Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation

Who this might be right for
Liver TransplantationChronic Renal Insufficiency
Armin Goralczyk 29
Not applicableStudy completedNCT00336817
What this trial is testing

A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipients

Who this might be right for
Immunosuppression
University of Pittsburgh 30
Testing effectiveness (Phase 2)Study completedNCT01128335
What this trial is testing

Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 200
Post-approval studies (Phase 4)Looking for participantsNCT05242315
What this trial is testing

Extended-Release Tacrolimus Following Liver Transplantation

Who this might be right for
Liver Transplant; ComplicationsRenal InsufficiencyImmunosuppressant Adverse Reaction+2 more
University of Alberta 94
Next Page